| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.1M | — | +116.8% |
| Cost of Revenue | $5.8M | — | +43.2% |
| Gross Profit | $5.3M | — | +390.0% |
| R&D Expense | $995K | — | -1.5% |
| SG&A Expense | $4.5M | — | +32.0% |
| Operating Income | -$3.6M | — | +38.6% |
| Interest Expense | $44K | — | -71.9% |
| Pre-tax Income | -$3.4M | — | +39.6% |
| Income Tax | $151K | — | — |
| Net Income | -$3.6M | — | +36.9% |
| EPS (Basic) | -$0.02 | — | +33.3% |
| EPS (Diluted) | -$0.02 | — | +33.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $16.0M | +398.4% | +0.7% |
| Accounts Receivable | $14.1M | +13.4% | +254.7% |
| Inventory | $17.1M | +0.0% | +19.4% |
| Current Assets | $66.3M | +35.8% | +39.1% |
| Total Assets | $90.5M | +22.0% | +42.7% |
| Current Liabilities | $26.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.3M | — | +62.1% |
| Capital Expenditures | $54K | — | -93.8% |
| Investing Cash Flow | -$54K | — | +93.8% |
| Financing Cash Flow | $18.2M | — | -19.0% |
| Free Cash Flow | -$2.4M | — | +66.1% |
| +73.7% |
| Total Liabilities | $36.0M | +0.0% | +57.3% |
| Stockholders' Equity | $54.5M | +42.7% | +34.4% |